跳至主要内容
临床试验/PACTR202302536807007
PACTR202302536807007尚未招募4 期

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics (INTREPiD)

Duke Clinical Research Institute0 个研究点目标入组 2,500 人开始时间: 2023年2月23日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
2,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
Female

入选标准

  • Aged between 16 years and 40 years (inclusive)
  • Viable singleton pregnancy with gestational age estimated less than 13 6/7
  • weeks (inclusive) by ultrasound
  • HIV-uninfected
  • Willing to participate in the study schedule
  • Planning to remain in the study area for the duration of pregnancy and 1
  • month after delivery
  • Willing to deliver in a study-affiliated health facility

排除标准

  • High risk pregnancy that requires referral for specialized care by local
  • Active medical problem at the time of screening requiring higher level care
  • Antimalarial receipt in the 2 weeks prior to screening
  • Past allergy to Artemether or Lumefantrine or another condition that
  • prohibits the receipt of either drug
  • Current participation in another clinical research study

研究者

相似试验